Effect of Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy
This randomized trial compares the effect of recombinant human soluble thrombomodulin vs placebo in patients with sepsis-associated coagulopathy on 28-day all-cause mortality.
Source: JAMA - Journal of the American Medical Association - Category: General Medicine Source Type: research
More News: American Medical Association (AMA) | General Medicine